Free Trial

Auna (NYSE:AUNA) Rating Lowered to "Buy" at Wall Street Zen

Auna logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Auna from “strong buy” to “buy,” while Weiss Ratings maintained a “sell (d)” rating. Overall, analysts have a consensus “hold” rating and an average price target of $6.97.
  • Auna shares opened at $4.52, near the lower end of their 52-week range of $4.09 to $6.29. The stock has a market capitalization of approximately $334.5 million and trades at a P/E ratio of 64.58.
  • In its latest quarter, Auna reported revenue of $362.85 million, exceeding estimates, but earnings per share of $0.15 fell short of the $0.26 consensus forecast.
  • Five stocks we like better than Auna.

Auna (NYSE:AUNA - Get Free Report) was downgraded by Wall Street Zen from a "strong-buy" rating to a "buy" rating in a note issued to investors on Sunday, Wall Street Zen reports.

Separately, Weiss Ratings reiterated a "sell (d)" rating on shares of Auna in a report on Monday, September 21st. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Auna currently has a consensus rating of "Hold" and an average target price of $6.97.

View Our Latest Analysis on Auna

Auna Stock Performance

NYSE:AUNA opened at $4.52 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.00 and a debt-to-equity ratio of 1.61. Auna has a 1-year low of $4.09 and a 1-year high of $6.29. The stock has a market cap of $334.53 million, a P/E ratio of 64.58 and a beta of 0.62. The stock's 50-day moving average is $5.15 and its 200-day moving average is $5.12.

Auna (NYSE:AUNA - Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.26 by ($0.11). The company had revenue of $362.85 million for the quarter, compared to analyst estimates of $357.39 million. Auna had a net margin of 0.44% and a return on equity of 12.88%. Equities research analysts anticipate that Auna will post 0.79 earnings per share for the current year.

Institutional Investors Weigh In On Auna

A number of institutional investors and hedge funds have recently modified their holdings of the company. WINTON GROUP Ltd purchased a new position in shares of Auna during the 2nd quarter valued at $98,000. Squarepoint Ops LLC purchased a new stake in Auna in the second quarter worth $149,000. AXQ Capital LP grew its stake in Auna by 72.3% in the second quarter. AXQ Capital LP now owns 24,637 shares of the company's stock worth $126,000 after purchasing an additional 10,335 shares during the period. Bank of America Corp DE lifted its holdings in shares of Auna by 255.9% during the first quarter. Bank of America Corp DE now owns 16,886 shares of the company's stock valued at $93,000 after purchasing an additional 12,142 shares during the last quarter. Finally, Lazard Asset Management LLC bought a new position in Auna in the 1st quarter worth about $557,000.

About Auna

(Get Free Report)

Auna SA is a Latin American healthcare company that provides integrated medical services through a network of hospitals, clinics, outpatient centers and specialized care facilities. Its operations include hospital care, ambulatory services, diagnostic testing, oncology treatment, preventive care and other medical specialties.

The company also offers healthcare plans and programs designed to provide access to medical services, including specialized oncology coverage. Auna's business model combines healthcare financing and service delivery, allowing it to serve patients across different stages of care, from prevention and diagnosis to treatment and follow-up.

Auna is headquartered in Peru and serves markets in Latin America, including Peru, Colombia and Mexico.

Read More

Analyst Recommendations for Auna (NYSE:AUNA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Auna Right Now?

Before you consider Auna, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Auna wasn't on the list.

While Auna currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines